Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Huihai Zhong"'
Autor:
Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li, Huihai Zhong, Tan Li, Zecong Xiao, Yong Wang, Xintao Shuai
Publikováno v:
Aggregate, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract Nanodrugs capable of aggregating in the tumor microenvironment (TME) have demonstrated great efficiency in improving the therapeutic outcome. Among various approaches, the strategy utilizing electrostatic interaction as a driving force to ac
Externí odkaz:
https://doaj.org/article/0026e649f0024bf1a63cb790aaafe622
Autor:
Bo Li, Yuejun Lin, Gengjia Chen, Mingyue Cai, Huihai Zhong, Zecong Xiao, Minzhao Lin, Tan Li, Yujun Cai, Xintao Shuai, Jie Ren
Publikováno v:
Advanced Science, Vol 10, Iss 33, Pp n/a-n/a (2023)
Abstract The protective blood‐brain barrier (BBB) prevents most therapeutic agents from entering the brain. Currently, focused ultrasound (FUS) is mostly employed to create microbubbles that induce a cavitation effect to open the BBB. However, micr
Externí odkaz:
https://doaj.org/article/b61c6a14d7a44d8babf85f8d2774c836
Autor:
Dongbing Ding, Huihai Zhong, Rongpu Liang, Tianyun Lan, Xudong Zhu, Shengxin Huang, Yong Wang, Jun Shao, Xintao Shuai, Bo Wei
Publikováno v:
Advanced Science, Vol 8, Iss 14, Pp n/a-n/a (2021)
Abstract An ideal tumor treatment is supposed to eliminate the primary tumor and simultaneously trigger the host antitumor immune responses to prevent tumor recurrence and metastasis. Herein, a liposome encapsulating phosphoinositide 3‐kinase gamma
Externí odkaz:
https://doaj.org/article/6ea77f7c60ba40abab897ec11afe5b7d
Autor:
Dongdong Li, Meng Zhang, Fan Xu, Yingzhi Chen, Binfan Chen, Ya Chang, Huihai Zhong, Hongyue Jin, Yongzhuo Huang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 8, Iss 1, Pp 74-84 (2018)
Nanotechnology-based photothermal therapy has attracted great attention in the past decade. Nevertheless, photothermal therapy has some inherent drawbacks, such as the uneven heat production and limited laser penetration, often leading to insufficien
Externí odkaz:
https://doaj.org/article/d8be38e39ba1481692e9aa6a46dd9217
Autor:
Huihai Zhong, Gengjia Chen, Tan Li, Jinsheng Huang, Minzhao Lin, Bo Li, Zecong Xiao, Xintao Shuai
Publikováno v:
Nano Letters.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbc6bd43d90df91c367724d507d2f61e
https://doi.org/10.1021/acs.nanolett.3c01008
https://doi.org/10.1021/acs.nanolett.3c01008
Publikováno v:
Biomaterials. 296:122067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e724db64c57ac3b65995fbc418bccde
https://doi.org/10.1016/j.biomaterials.2023.122067
https://doi.org/10.1016/j.biomaterials.2023.122067
Autor:
Tan Li, Gengjia Chen, Zecong Xiao, Bo Li, Huihai Zhong, Minzhao Lin, Yujun Cai, Jing Huang, Xi Xie, Xintao Shuai
Publikováno v:
Nano letters. 22(7)
Recent breakthroughs in cell membrane-fabricated nanovaccine offer innovateive therapeutic options for preventing tumor metastasies and recurrence, yet the treatment of patient-specific solid tumor remained challenging owing to the immunosuppressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00fe2a341fbd3d7f43492a54935cd4b
https://pubmed.ncbi.nlm.nih.gov/35357839
https://pubmed.ncbi.nlm.nih.gov/35357839
Autor:
Lihua Du, Haozhe He, Zecong Xiao, Hong Xiao, Yongcheng An, Huihai Zhong, Minzhao Lin, Xiaochun Meng, Shisong Han, Xintao Shuai
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 18(15)
Immunotherapy brings great benefits for tumor therapy in clinical treatments but encounters the severe challenge of low response rate mainly because of the immunosuppressive tumor microenvironment. Multifunctional nanoplatforms integrating effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f64f2e08b45a53d0bfb4417ceb7f645
https://pubmed.ncbi.nlm.nih.gov/35218310
https://pubmed.ncbi.nlm.nih.gov/35218310
Publikováno v:
Acta Pharmacologica Sinica
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), also known as APO2L, belongs to the tumor necrosis factor family. By binding to the death receptor 4 (DR4) or DR5, TRAIL induces apoptosis of tumor cells without causing side toxicity i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1350166ac78cc1b4d4902bff3b79f144
https://doi.org/10.1038/s41401-019-0287-8
https://doi.org/10.1038/s41401-019-0287-8
Autor:
Tianyun Lan, Xudong Zhu, Rongpu Liang, Huihai Zhong, Xintao Shuai, Dongbing Ding, Bo Wei, Shengxin Huang, Jun Shao, Yong Wang
Publikováno v:
Advanced Science
Advanced Science, Vol 8, Iss 14, Pp n/a-n/a (2021)
Advanced Science, Vol 8, Iss 14, Pp n/a-n/a (2021)
An ideal tumor treatment is supposed to eliminate the primary tumor and simultaneously trigger the host antitumor immune responses to prevent tumor recurrence and metastasis. Herein, a liposome encapsulating phosphoinositide 3‐kinase gamma (PI3Kγ)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d0e9834a416296d4bdb14d8796079b
http://europepmc.org/articles/PMC8292876
http://europepmc.org/articles/PMC8292876